Coloplast A/S (CLPBY)
12.56
+0.20
(+1.62%)
USD |
OTCM |
May 17, 16:00
Coloplast Profit Margin (Quarterly): 19.01% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 19.01% |
| December 31, 2023 | 18.35% |
| September 30, 2023 | 19.74% |
| June 30, 2023 | 20.83% |
| March 31, 2023 | 19.06% |
| December 31, 2022 | 18.46% |
| September 30, 2022 | 20.30% |
| June 30, 2022 | 22.04% |
| March 31, 2022 | 17.81% |
| December 31, 2021 | 23.35% |
| September 30, 2021 | 25.59% |
| June 30, 2021 | 25.94% |
| March 31, 2021 | 23.77% |
| December 31, 2020 | 23.98% |
| September 30, 2020 | 22.68% |
| June 30, 2020 | 22.56% |
| March 31, 2020 | 22.12% |
| December 31, 2019 | 23.17% |
| September 30, 2019 | 17.17% |
| June 30, 2019 | 23.22% |
| March 31, 2019 | 23.20% |
| December 31, 2018 | 22.93% |
| September 30, 2018 | 24.54% |
| June 30, 2018 | 22.44% |
| March 31, 2018 | 22.75% |
| Date | Value |
|---|---|
| December 31, 2017 | 23.77% |
| September 30, 2017 | 25.38% |
| June 30, 2017 | 23.26% |
| March 31, 2017 | 23.99% |
| December 31, 2016 | 25.19% |
| September 30, 2016 | 11.34% |
| June 30, 2016 | 26.53% |
| March 31, 2016 | 25.44% |
| December 31, 2015 | 22.57% |
| September 30, 2015 | -39.27% |
| June 30, 2015 | 20.03% |
| March 31, 2015 | 23.64% |
| December 31, 2014 | 24.14% |
| September 30, 2014 | 26.17% |
| June 30, 2014 | 25.14% |
| March 31, 2014 | -0.63% |
| December 31, 2013 | 25.47% |
| September 30, 2013 | 25.22% |
| June 30, 2013 | 24.00% |
| March 31, 2013 | 22.34% |
| December 31, 2012 | 21.54% |
| September 30, 2012 | 21.34% |
| June 30, 2012 | 20.79% |
| March 31, 2012 | 19.09% |
| December 31, 2011 | 18.24% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
17.17%
Minimum
Sep 2019
25.94%
Maximum
Jun 2021
21.46%
Average
22.08%
Median
Profit Margin (Quarterly) Benchmarks
| Genmab A/S | 31.98% |
| Ascendis Pharma A/S | -136.6% |
| Galecto Inc | -- |
| Evaxion Biotech AS | -6.20K% |
| IO Biotech Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 40.08% |
| Return on Assets | 11.55% |
| Return on Invested Capital | 14.88% |
| Gross Profit Margin (Quarterly) | 67.98% |
| Operating Margin (Quarterly) | 27.19% |
| Return on Net Operating Assets | 12.04% |